NCT02288429View on ClinicalTrials.gov

Evaluation of Pharmacokinetic and Pharmacodynamic Properties of Intravenous Colistimethate Sodium

CompletedOBSERVATIONAL
Enrollment

16

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

June 30, 2019

Study Completion Date

June 30, 2019

Conditions
Colistin
Interventions
DRUG

colistimethate sodium

Trial Locations (1)

80045

University of Colorado Hospital, Aurora

All Listed Sponsors
lead

University of Colorado, Denver

OTHER

NCT02288429 - Evaluation of Pharmacokinetic and Pharmacodynamic Properties of Intravenous Colistimethate Sodium | Biotech Hunter | Biotech Hunter